| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.10262 |
| P698 | PubMed publication ID | 12858356 |
| P50 | author | Hiroshi Miyamoto | Q38804576 |
| P2093 | author name string | Hitoshi Kitamura | |
| Yoshinobu Kubota | |||
| Hiroji Uemura | |||
| Yasuhide Miyoshi | |||
| Hitoshi Ishiguro | |||
| Kiyoshi Fujinami | |||
| Yoshiko Miyoshi | |||
| P2860 | cites work | Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts | Q24647178 |
| P433 | issue | 4 | |
| P304 | page(s) | 280-286 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer | |
| P478 | volume | 56 |
| Q24298056 | Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status |
| Q42261015 | Androgen Receptor-Target Genes in African American Prostate Cancer Disparities |
| Q38391360 | Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer |
| Q34542007 | Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis |
| Q36443392 | Diverse roles for the paxillin family of proteins in cancer |
| Q42069568 | Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade. |
| Q34495620 | Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness |
| Q38318721 | HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription |
| Q35923246 | Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8 |
| Q35925292 | Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. |
| Q36344198 | Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer |
| Q37053886 | Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment |
| Q34682069 | Prognostic factors in prostate cancer |
| Q38132914 | Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility |
| Q27025212 | Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases |
| Q59807253 | Role of Pyk2 in Human Cancers |
| Q34053767 | VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells |
Search more.